Mealey's (August 16, 2016, 11:39 AM EDT) -- PHILADELPHIA — A special discovery master on Aug. 10 recommended that the U.S. District Court for the Eastern District of Pennsylvania allow 27 thalidomide plaintiffs to dismiss their claims against GlaxoSmithKline LLC (GSK) with prejudice because, after a court-ordered investigation that included interviewing all plaintiffs, he found that the plaintiffs want to dismiss (Glenda Johnson, et al. v. SmithKline Beecham Corporation, et al., No. 11-5782, E.D. Pa.).

(Report and recommendation available. Document #28-160818-010X.)

In 2011, the plaintiff law firm of Hagens Berman Sobol Shapiro in Seattle...